DIVA Laboratories, Ltd. (TPEX:4153)

Market Cap	1.97B -10.8%
Revenue (ttm)	862.38M +2.2%
Net Income	83.92M -8.3%
EPS	1.42 -8.9%
Shares Out	58.67M
PE Ratio	23.62
Forward PE	n/a
Dividend	1.48 (4.40%)
Ex-Dividend Date	Jun 13, 2025

Volume	10,015
Average Volume	25,115
Open	34.10
Previous Close	33.90
Day's Range	33.00 - 34.10
52-Week Range	31.30 - 44.25
Beta	0.26
RSI	43.89
Earnings Date	Mar 20, 2026

About DIVA Laboratories

DIVA Laboratories, Ltd. engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. The company provides endo/surgical displays, a static and dynamic image for hybrid and integrated ORs applications; color and mono displays for radiology and medical imaging applications; touch displays/human machine interface products; medical and industrial cases; and displays to original design manufacturers (ODM) and original equipment manufacturers (OEMs) customers. It also offers emergency room/ operating ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1995
• Employees: 154
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4153

Financial Performance

In 2024, DIVA Laboratories's revenue was 862.32 million, a decrease of -3.53% compared to the previous year's 893.84 million. Earnings were 93.66 million, an increase of 27.23%.